Fulgent Genetics Return on Tangible Equity 2015-2025 | FLGT

Current and historical return on tangible equity values for Fulgent Genetics (FLGT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Fulgent Genetics Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.04B $0.97B -4.33%
2024-12-31 $-0.04B $0.97B -4.43%
2024-09-30 $-0.17B $0.98B -17.03%
2024-06-30 $-0.16B $0.97B -16.82%
2024-03-31 $-0.17B $0.96B -17.00%
2023-12-31 $-0.17B $0.97B -17.15%
2023-09-30 $-0.06B $0.98B -6.45%
2023-06-30 $-0.05B $0.98B -4.80%
2023-03-31 $-0.03B $0.98B -2.42%
2022-12-31 $0.14B $0.98B 13.16%
2022-09-30 $0.27B $1.07B 24.29%
2022-06-30 $0.39B $1.10B 36.01%
2022-03-31 $0.46B $1.23B 44.37%
2021-12-31 $0.51B $1.08B 54.46%
2021-09-30 $0.57B $0.96B 70.79%
2021-06-30 $0.49B $0.89B 80.69%
2021-03-31 $0.42B $0.80B 101.40%
2020-12-31 $0.21B $0.57B 92.64%
2020-09-30 $0.05B $0.19B 43.84%
2020-06-30 $0.00B $0.09B 2.61%
2020-03-31 $0.00B $0.08B -1.48%
2019-12-31 $0.00B $0.08B -1.67%
2019-09-30 $0.00B $0.06B -5.80%
2019-06-30 $-0.01B $0.05B -9.76%
2019-03-31 $-0.01B $0.05B -11.59%
2018-12-31 $-0.01B $0.05B -11.43%
2018-09-30 $-0.01B $0.05B -11.27%
2018-06-30 $-0.01B $0.05B -11.16%
2018-03-31 $-0.01B $0.05B -9.17%
2017-12-31 $0.00B $0.05B -5.45%
2017-09-30 $0.00B $0.06B 0.00%
2017-06-30 $0.00B $0.06B 0.00%
2017-03-31 $-0.01B $0.06B -13.51%
2016-12-31 $-0.01B $0.05B -25.81%
2016-06-30 $-0.01B $0.02B -109.09%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.618B $0.283B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.989B 58.51
Hims & Hers Health (HIMS) United States $13.669B 142.02
Tempus AI (TEM) United States $11.962B 0.00
IRhythm Technologies (IRTC) United States $4.646B 0.00
Inspire Medical Systems (INSP) United States $3.825B 59.77
Hinge Health (HNGE) United States $3.100B 0.00
Privia Health (PRVA) United States $2.659B 181.75
Enovis (ENOV) United States $1.751B 9.76
Schrodinger (SDGR) United States $1.545B 0.00
Phreesia (PHR) United States $1.527B 0.00
Clover Health Investments (CLOV) United States $1.511B 0.00
Azenta (AZTA) United States $1.371B 63.70
10x Genomics (TXG) United States $1.338B 0.00
Omnicell (OMCL) United States $1.324B 23.36
Claritev (CTEV) United States $0.663B 0.00
Butterfly Network (BFLY) United States $0.534B 0.00
Veradigm (MDRX) United States $0.482B 0.00
Talkspace (TALK) United States $0.463B 138.50
Standard BioTools (LAB) United States $0.414B 0.00
Outset Medical (OM) United States $0.347B 0.00
TruBridge (TBRG) United States $0.346B 766.67
Nyxoah SA (NYXH) Belgium $0.263B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.150B 0.00
EUDA Health Holdings (EUDA) Singapore $0.139B 0.00
Pulmonx (LUNG) United States $0.111B 0.00
CareCloud (CCLD) United States $0.107B 4.06
American Well (AMWL) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.096B 0.00
111 (YI) China $0.068B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.046B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00